Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

97.75
+0.90000.93%
Volume:138.84K
Turnover:13.48M
Market Cap:24.56B
PE:-12.58
High:97.84
Open:97.35
Low:96.22
Close:96.85
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:109.00M
Volume Ratio:1.84
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.23
PE(LYR):-17.71

Loading ...

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

TIPRANKS
·
Aug 28

Pfizer, BioNTech Win FDA Approval for XFG-Adapted COVID-19 Vaccine in High-Risk US Adults

Reuters
·
Aug 28

Is BioNTech (BNTX) Priced Too Richly For Its Lung Cancer Promise?

Simply Wall St.
·
Aug 26

Warburg Research Remains a Hold on Deutsche Euroshop (0I3Z)

TIPRANKS
·
Aug 26

Leonteq revamps board and faces shareholder push on share buyback and director pay

TIPRANKS
·
Aug 25

European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Monday Trading

MT Newswires Live
·
Aug 24

BioNTech (BNTX) Is Up 27.3% After Novel Pumitamig Combo Data in Lung Cancer – Has The Bull Case Changed?

Simply Wall St.
·
Aug 24

BioNTech SE ADR Rises 5.1%, Outperforms Market

Dow Jones
·
Aug 22

Why Retail Investors Are Tracking Founder Led Stocks Like Baidu And BioNTech

Simply Wall St.
·
Aug 22

BioNTech’s New HIV RNA Vaccine Trial: What Investors Should Watch Now

TIPRANKS
·
Aug 22

European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

MT Newswires Live
·
Aug 21

Arbutus Biopharma Shares Rise on $230 Million Stock Buyback

Dow Jones
·
Aug 21

Movement Alert|BioNTech SE Rises 5.69% in Regular Trading, mRNA Cancer Vaccine Phase III Trial Success Continues to Lift Sector

Market Focus
·
Aug 21

Founder Led Stocks Worth Watching As Markets Reward Long Term Builders

Simply Wall St.
·
Aug 20

BioNTech: Cash-Rich Oncology Pipeline Supports Sentiment, But Clinical and Valuation Uncertainties Warrant Hold Rating

TIPRANKS
·
Aug 20

How Moderna’s Cancer Breakthrough Reversed Its Fortunes and Revived the Stock

Dow Jones
·
Aug 20

BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.

Dow Jones
·
Aug 20

BioNTech SE ADR Advances 22.0%, Outperforms Market

Dow Jones
·
Aug 20

JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)

TIPRANKS
·
Aug 20

U.S. Stocks on the MOVE-Marvell, Pilgrim's Pride, ServiceNow

Reuters
·
Aug 19